You have probably heard of monoclonal antibodies as drugs that help fight COVID-19. Now, a monoclonal antibody developed strictly for relieving arthritis pain in cats has been approved by the Food and Drug Administration (FDA). Called Solensia (generic name frunevetmab injection), it is actually the first monoclonal antibody approved for use in any species other […]
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Tufts Catnip
Get the next year of TUFTS CATNIP for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 44%. It's like getting 5 months FREE!